PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Lobelane dose-dependently decreased methamphetamine self-administration [PMID: 17612524].
Pretreatment with lobeline (3.0-30 mg/kg) significantly decreased the intensity of stereotypy and increased latency to onset in a dose-dependent manner [PMID: 17053968].
Different degrees of isomerization of lobeline injections showed significant differences in respiratory excitatory effects; cis-lobeline exhibited a stronger effect than those with higher isomerization [PMID: 36234790].
Evidence summary
PubMed sources
- 1.PMID: 25202618 (2014) — Development of polymorphic microsatellite markers for Indian tobacco, Lobelia inflata (Campanulaceae)(1.). · Applications in plant sciences
- 2.PMID: 17612524 (2007) — Lobelane decreases methamphetamine self-administration in rats. · European journal of pharmacology
- 3.PMID: 40149916 (2025) — Interplay Between Traditional and Scientific Knowledge: Phytoconstituents and Their Roles in Lung and Colorectal Cancer Signaling Pathways. · Biomolecules
- 4.PMID: 36234790 (2022) — From cis-Lobeline to trans-Lobeline: Study on the Pharmacodynamics and Isomerization Factors. · Molecules (Basel, Switzerland)
- 5.PMID: 26259655 (2015) — HPLC-ESI-MS/MS of brain neurotransmitter modulator lobeline and related piperidine alkaloids in Lobelia inflata L.